Latest Trials

Systemic therapy trial

A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety,...

This phase II trial is evaluating two drugs (oral GSK525762 tablets and a Fulvestrant injection) in patients with a breast cancer that has spread to other parts of the body and progressed after a previous treatment

Status : Recruiting

Systemic therapy trial

PRIMULA : A Phase III, Double-Blind, Placebo-Controlled, Multicenter, Randomized Study Of...

This phase III trial is combining two drugs (Pracinostat and Azacitidine) in patients with newly diagnosed Acute Myeloid Leukaemia (AML)

Status : Recruiting

Systemic therapy trial

TRITON2 : A Multicenter, Open-label Phase 2 Study of Rucaparib in Patients With Metastatic...

This phase II trial is evaluating the effect of the anti-cancer drug Rucaparib in patients with metastatic castration-resistant prostate cancer

Status : Recruiting

Systemic therapy trial

CLEAR : A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety...

This phase III trial is comparing three drugs (Lenvatinib in combination with Everolimus or Pembrolizumab) with another targeted drug (Sunitinib) as a first-line treatment for patients with advanced Renal Cell Carcinoma

Status : Recruiting

Systemic therapy trial

Xcovery XALT3 : Phase 3 Randomized Study Comparing X-396 (Ensartinib) to Crizotinib in Anaplastic...

This phase III trial is evaluating the safety and efficacy of X-396 (ensartinib), compared to crizitonib, in patients with ALK+ Non-Small Cell (NSC) lung cancer

Status : Recruiting

Systemic therapy trial

B-MIND : A Phase 2/3, Randomised, Multicentre Study of MOR208 With Bendamustine Versus Rituximab...

This phase II/III trial is combining bendamustine (a chemotherapy drug) with either MOR208 or rituximab (two types of antibody therapy) for the treatment of Diffuse Large B-cell Lymphoma

Status : Recruiting

Systemic therapy trial

DREAM : A phase 2 trial of durvalumab with first line chemotherapy in mesothelioma with a safety...

This phase II trial is combining a drug (durvalumab) and first line chemotherapy for the treatment of mesothelioma

Status : Recruiting

Systemic therapy trial

CanStem111P : A Phase III Study of BBI-608 Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With...

This phase III trial is evaluating a new inhibitor drug (BBI-608) with two anti-cancer chemotherapy drugs (nab-paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer

Status : Recruiting

Systemic therapy trial

PERSPECTIVE : A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study of the Bruton's...

This phase III trial is trying to determine the benefit of adding an immunotherapy drug (Ibrutinib) to Rituximab treatment in patients who have been diagnosed with Follicular Lymphoma and not yet received treatment

Status : Recruiting

Systemic therapy trial

ATTAIN : A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of...

This phase III trial is comparing the drug NKTR-102 with a treatment chosen by the doctor in patients who have have been treated for breast cancer that has spread to the brain

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.